Stock Research: Panion & Bf Biotech

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Panion & Bf Biotech

TSEC:1760 TW0001760007
4
  • Value
    22
  • Growth
    12
  • Safety
    Safety
    24
  • Combined
    4
  • Sentiment
    43
  • 360° View
    360° View
    4
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

PANION & BF BIOTECH INC. manufactures and sells western medicines, experimental drugs, and cosmetics. The company also offers formula food, medical devices, animal and pet drugs, feed, and environmental health drugs, in addition to biotechnology services. It operates in the pharmaceuticals, cosmetics, and biotechnology industries. Its primary markets are Taiwan, mainland China, Hong Kong, and Macau. In the last fiscal year, the company had a market cap of $211 million, profits of $33 million, and revenue of $62 million. The number of employees is not available.

more
Index
FTSE Taiwan
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 24 28 29
Growth
12 10 71 69
Safety
Safety
24 18 32 14
Sentiment
43 46 37 65
360° View
360° View
4 1 32 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
16 12 20 24
Opinions Change
50 50 50 50
Pro Holdings
n/a 28 24 90
Market Pulse
100 100 100 n/a
Sentiment
43 46 37 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 24 28 29
Growth
12 10 71 69
Safety Safety
24 18 32 14
Combined
4 1 37 24
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
26 17 33 53
Price vs. Earnings (P/E)
25 26 22 31
Price vs. Book (P/B)
27 17 16 20
Dividend Yield
76 52 57 33
Value
22 24 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
24 6 89 47
Profit Growth
57 18 59 7
Capital Growth
26 46 70 78
Stock Returns
12 36 9 81
Growth
12 10 71 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
29 30 43 1
Refinancing
24 11 17 13
Liquidity
43 28 67 39
Safety Safety
24 18 32 14

Similar Stocks

Discover high‑ranked alternatives to Panion & Bf Biotech and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Shionogi

TSE:4507
Country: Japan
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Asustek Computer

TSEC:2357
Country: Taiwan
Industry: Technology Hardware & Peripherals
Size: Large
Full Stock Analysis

Ono Pharmaceutical

TSE:4528
Country: Japan
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: